Skip to content
Open in App
Viatris logo

Viatris

web2

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America...

Symbol · VIA1
Company profile

About

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, oncology, and respiratory and allergy, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. In addition, the company offers medicines in the form of oral solid doses, injectables, and complex dosage forms to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies under the Lyrica, Lipitor, Celebrex, Viagra, Creon, Influvac, Wixela Inhub, EpiPen Auto-Injector, Fraxiparine, Yupelri, Norvasc, Amitiza, Effexor, Lipacreon, Zoloft, Xalabrands, Dymista, Xanax, and Breyna brands. The company has collaboration agreements with Mapi Pharma Ltd. to develop and commercialize long-acting glatiramer acetate depot products and additional products; Revance Therapeutics, Inc. to develop, manufacture, and commercialize a biosimilar to the branded biologic product, BOTOX; and Theravance Biopharma, Inc. to develop and commercialize revefenacin. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

People

Company team

FA

Frank A. D'Amelio

Independent Director

Company leadership profile.

EW

Elisha Wade Finney

Independent Director

Company leadership profile.

ME

Melina E. Higgins

Independent Non-Executive Chairman

Company leadership profile.

SA

Scott Andrew Smith

CEO & Director

Company leadership profile.

MW

Mark W. Parrish

Independent Vice Chairman & Lead Independent Director

Company leadership profile.

JL

JoEllen Lyons Dillon

Independent Non-Executive Director

Company leadership profile.

RA

Richard A. Mark

Independent Director

Company leadership profile.

WD

Wyllie Don Cornwell

Independent Director

Company leadership profile.

JM

James Marshall Kilts

Independent Director

Company leadership profile.

LG

Leo Groothuis

Independent Director

Company leadership profile.

RV

Rogerio Vivaldi Coelho

Independent Director

Company leadership profile.

ME

Michael E. Severino

Independent Director

Company leadership profile.

DS

David S. Simmons

Independent Director

Company leadership profile.

Expert coverage

1 expert evaluated Viatris.

Orbitrum research

Experts evaluating Viatris

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment